Anti-FKBP8 monoclonal antibody

Pre-made anti-FKBP8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FKBP8/FKBP8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0851-Ab-1/ GM-Tg-hg-IP0851-Ab-2Anti-Human FKBP8 monoclonal antibodyHuman
GM-Tg-rg-IP0851-Ab-1/ GM-Tg-rg-IP0851-Ab-2Anti-Rat FKBP8 monoclonal antibodyRat
GM-Tg-mg-IP0851-Ab-1/ GM-Tg-mg-IP0851-Ab-2Anti-Mouse FKBP8 monoclonal antibodyMouse
GM-Tg-cynog-IP0851-Ab-1/ GM-Tg-cynog-IP0851-Ab-2Anti-Cynomolgus/ Rhesus macaque FKBP8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0851-Ab-1/ GM-Tg-felg-IP0851-Ab-2Anti-Feline FKBP8 monoclonal antibodyFeline
GM-Tg-cang-IP0851-Ab-1/ GM-Tg-cang-IP0851-Ab-2Anti-Canine FKBP8 monoclonal antibodyCanine
GM-Tg-bovg-IP0851-Ab-1/ GM-Tg-bovg-IP0851-Ab-2Anti-Bovine FKBP8 monoclonal antibodyBovine
GM-Tg-equg-IP0851-Ab-1/ GM-Tg-equg-IP0851-Ab-2Anti-Equine FKBP8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0851-Ab-1/ GM-Tg-hg-IP0851-Ab-2; GM-Tg-rg-IP0851-Ab-1/ GM-Tg-rg-IP0851-Ab-2;
GM-Tg-mg-IP0851-Ab-1/ GM-Tg-mg-IP0851-Ab-2; GM-Tg-cynog-IP0851-Ab-1/ GM-Tg-cynog-IP0851-Ab-2;
GM-Tg-felg-IP0851-Ab-1/ GM-Tg-felg-IP0851-Ab-2; GM-Tg-cang-IP0851-Ab-1/ GM-Tg-cang-IP0851-Ab-2;
GM-Tg-bovg-IP0851-Ab-1/ GM-Tg-bovg-IP0851-Ab-2; GM-Tg-equg-IP0851-Ab-1/ GM-Tg-equg-IP0851-Ab-2
Products NameAnti-FKBP8 monoclonal antibody
Formatmab
Target NameFKBP8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FKBP8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0851-Ag-1Recombinant multi-species FKBP8/ FKBP38/ FKBPr38 protein


    Target information

    Target IDGM-IP0851
    Target NameFKBP8
    Gene ID23770,14232,290652,720232,484819,101087821,512356,100069569
    Gene Symbol and Synonyms38kDa,FKBP-38,FKBP-8,FKBP38,FKBP8,FKBPr38,mFKBP38
    Uniprot AccessionQ14318,Q3B7U9
    Uniprot Entry NameFKBP8_HUMAN,FKBP8_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105701
    Target ClassificationN/A

    The target: FKBP8, gene name: FKBP8, also named as FKBP38, FKBPr38. The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. Unlike the other members of the family, this encoded protein does not seem to have PPIase/rotamase activity. It may have a role in neurons associated with memory function. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.